Invision Pharma Limited

Pharmaceutical company with online portal offering tablets, capsules, and ointment.

2018 | Bangaluru, Karnataka (India) | Active
Last Updated:

Invision Pharma Profile

Key Indicators

  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.50 M
  • Company Age 6 Year, 11 Months
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth 75.81%
  • Profit Growth -980.93%
  • Ebitda -327.46%
  • Net Worth -394.65%
  • Total Assets 79.45%

About Invision Pharma

Invision Pharma Limited (IPL) is a Public Limited Indian Non-Government Company incorporated in India on 21 May 2018 (Six years and 11 months 14 days old ). Its registered office is in Bangaluru, Karnataka, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.

Mukeshkumar, Nataraj Nanjundappa, and Chirag Mukeshkumar serve as directors at the Company.

Company Details

  • Location

    Bangaluru, Karnataka, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U24304KA2018PLC113264

  • Company No.

    113264

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    21 May 2018

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Bangalore

Industry

Pharma
Company report

Invision Pharma Limited

Explore comprehensive data for Invision Pharma Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Invision Pharma?

Board Members (3)

NameDesignationAppointment DateStatus
Mukeshkumar Country flag representing In Director 21-May-2018Current
Nataraj Nanjundappa Country flag representing In Director 21-May-2018Current
Chirag Mukeshkumar Country flag representing In Director 21-May-2018Current

Financial Performance of Invision Pharma.

Invision Pharma Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 75.81% increase. The company also saw a substantial fall in profitability, with a 980.93% decrease in profit. The company's net worth observed a substantial decline by a decrease of 394.65%.

Invision Pharma revenue growth over time
Invision Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
75.81%
Revenue from Operations
75.83%
Total Assets
79.45%
Profit or Loss
-980.93%
Net Worth
-394.65%
EBITDA
-327.46%

What is the Ownership and Shareholding Structure of Invision Pharma?

In 2023, Invision Pharma had a promoter holding of 99.92% and a public holding of 0.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Invision Pharma?

Unlock and access historical data on people associated with Invision Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Invision Pharma Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Invision Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invision Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Invision Pharma

Recent activity within the organization

  • Annual General Meeting

    Invision Pharma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Invision Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore.

  • Director Appointment

    Mukeshkumar was appointed as a Director was appointed as a Director on 21 May 2018 & has been associated with this company since 6 years 11 months .

  • Director Appointment

    Nataraj Nanjundappa was appointed as a Director was appointed as a Director on 21 May 2018 & has been associated with this company since 6 years 11 months .

  • Director Appointment

    Chirag Mukeshkumar was appointed as a Director was appointed as a Director on 21 May 2018 & has been associated with this company since 6 years 11 months .

  • Company Incorporation

    Invision Pharma Limited was registered on 21 May 2018 with Roc Bangalore & aged 6 years 11 months as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Invision Pharma Limited?

    Invision Pharma Limited was incorporated on 21 May 2018.

  • What is authorized share capital and paid-up capital of Invision Pharma Limited?

    The authorized share capital of Invision Pharma Limited is ₹ 1.00 M and paid-up capital is ₹ 0.50 M.

  • Who are the current board members & directors of Invision Pharma Limited?

    Currently 3 directors are associated with Invision Pharma Limited.

    • Mukeshkumar
    • Nataraj Nanjundappa
    • Chirag Mukeshkumar
  • What is the registered address of Invision Pharma Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Invision Pharma Limited is 1St Floor No. 194/31/2/74-75 Begur Sub Zone Behind Metro Wholesale Beretena Agrahar A, India, Bengaluru, Karnataka, 560100.

  • What is the corporate identification number (CIN) and company number of Invision Pharma Limited?

    The corporate identification number (CIN) of Invision Pharma Limited is U24304KA2018PLC113264 and the company number is 113264 as per Ministry of Corporate Affairs (MCA).

  • What is the official website of Invision Pharma Limited?

    The Official website of Invision Pharma Limited is https://www.invisionpharma.com

  • What has been the recent revenue trend for Invision Pharma Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Invision Pharma Limited has risen by 75.81%.

  • What change has been observed in the net worth of Invision Pharma Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Invision Pharma Limited has experienced an downturn of -394.65%.

  • When was the last Balance Sheet of Invision Pharma Limited filed with the ROC?

    The most recent Balance Sheet for Invision Pharma Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Drug Formulation & Development